Brief: Xbiotech Announces Upcoming Phase 2 Clinical Studies In Dermatology
16/04/2018 13:01
April 16 (Reuters) - XBiotech Inc XBIT.O :
* XBIOTECH ANNOUNCES UPCOMING PHASE 2 CLINICAL STUDIES IN
DERMATOLOGY
* XBIOTECH INC - CONDUCTING FINAL PREPARATIONS FOR STUDY
LAUNCH
INCLUDING FIRST CLINICAL SITE INITIATION SCHEDULED LATER THIS
MONTH
Source text for Eikon: ID:nGNE7RH55t
Further company coverage: XBIT.O
(((Reuters.Briefs@thomsonreuters.com);;))
Recent news on XBiotech
See all newsBrief: XBiotech Announces Positive Final Efficacy Results From Phase II Taskin Trial
Brief: Xbiotech Launches Phase Ii Clinical Trial Evaluating Vilamakitug For The Treatment Of Active Axial Spondyloarthritis
Brief: Xbiotech Launches Phase Ii Clinical Trial Evaluating Vilamakitug For The Treatment Of Active Axial Spondyloarthritis
Brief: XBiotech Inc - John Simard To Retire As CEO Of XBiotech - SEC Filing
Brief: Xbiotech Announces Enrollment Completion Of Phase I Clinical Trial For Hutrukin, A Novel Candidate Therapy For Stroke